Consequence of Dexmedetomidine on Emergence Deliruim After Sevoflurane Anesthesia in Children With Cerebral Palsy
Emergence Deliruim; Cerebral Palsy
About this trial
This is an interventional prevention trial for Emergence Deliruim; Cerebral Palsy focused on measuring children
Eligibility Criteria
Inclusion Criteria:
Non-quadriplegic (mono-,di-, hemiplegic) children with CP that are scheduled for elective Achilles-tendon lengthening procedure Guangzhou Women and Children's Medical Center, Guangzhou, China, with American Society of Anesthesiologists (ASA) physical status I or II.
Exclusion Criteria:
Participants that displayed symptoms of sinus bradycardia and atrio-ventricular block, non-communicative severe developmental delay, seizure disorders, and treatment with seizure medications
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Placebo Comparator
Experimental
Group C
Group D
Five minutes prior to the commencement of the surgical procedure, Group D participants were administered 10 ml NaCI 0.9%.
Five minutes prior to the commencement of the surgical procedure, Group D participants were administered dexmedetomidine 0.5μg•kg-1 diluted in 10 ml NaCI 0.9%